"Escape" Phenomenon of the Antihypertensive Therapy Efficacy
NCT ID: NCT05436730
Last Updated: 2022-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
165 participants
OBSERVATIONAL
2015-09-29
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Antihypertensive Agents Over Sleep Apnea
NCT01896661
Effect of Plasma Sodium Concentration on Blood Pressure Regulators During Hemodialysis
NCT03578510
Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
NCT01091753
Intermittent Hypoxia 2: Cardiovascular and Metabolism
NCT02058823
Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population
NCT03484312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"Escape" Phenomenon of the Antihypertensive Therapy Efficacy
Men and women aged 18-90 years with arterial hypertension grade 1-3, stage I-II and initially achieved target BP levels while taking 2-3-component AHT.
Ambulatory blood pressure measurement device
Assessment of the 24-h blood pressure profile
Sphygmocor
Assessment of the arterial stiffness
VaSera-VS
Assessment of the arterial stiffness
Somnocheck
Assessment of the sleep breath disturbances
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ambulatory blood pressure measurement device
Assessment of the 24-h blood pressure profile
Sphygmocor
Assessment of the arterial stiffness
VaSera-VS
Assessment of the arterial stiffness
Somnocheck
Assessment of the sleep breath disturbances
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High compliance during the follow-up period (≥ 85%)
* Initially achieved target office BP levels while taking 2-3-component AHT
Exclusion Criteria
* Resistant AH,
* AH III stage,
* PAP- therapy,
* type 2 diabetes mellitus,
* pregnancy
* history of low adherence to treatment
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADE
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mikhailova Oksana
Dr., clinical reseacher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oksana Mikhailova
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
115061870017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.